Pharmacists’ Contribution to COVID-19 Drug Related Expenditures

Abstract

Get full access to this article

View all access options for this article.

References

Perez

Masse

Deldicque

, et al. Analysis of clinical pharmacist interventions in the COVID-19 units of a French university hospital. Eur J Hosp Pharm. 2022;29:e30-e35.

Al-Quteimat

Amer

AM.

SARS-CoV-2 outbreak: how can pharmacists help?

Res Social Adm Pharm. 2021;17(2):480-482.

US Department of Health and Human Services Public Health Emergency. Remdesivir for the Commercial Marketplace FAQs. 2020. Accessed March 22, 2022. https://www.phe.gov/emergency/events/COVID19/investigation-MCM/Pages/faq-remdesivir-commercial.aspx#about4.

COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. 2019. Accessed March 23, 2022. https://www.covid19treatmentguidelines.nih.gov/

World Health Organization. COVID-19 clinical management: living guidance. World Health Organization. 2021. Accessed March 23, 2022. Case management (who.int)

World Health Organization. Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19. 2020. Accessed March 23, 2022. https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/